How has been the historical performance of Integ. Proteins?

Answer:The historical performance of Integ. Proteins shows significant growth in net sales, reaching 21.50 Cr in March 2025, up from just 0.24 Cr in March 2024 and 0.17 Cr in March 2023. The total operating income also increased to 21.50 Cr in March 2025, compared to 0.24 Cr in the previous year. The company has seen a notable rise in operating profit, which stood at 0.34 Cr in March 2025, a substantial improvement from 0.14 Cr in March 2024. Profit before tax also increased to 0.32 Cr in March 2025, up from 0.10 Cr in March 2024, while profit after tax reached 0.25 Cr, compared to 0.09 Cr in the prior year. The earnings per share (EPS) rose to 0.71 in March 2025 from 0.26 in March 2024, reflecting a positive trend in profitability. Breakdown: Integ. Proteins has demonstrated a remarkable upward trajectory in its financial performance over the past few years. Starting from no sales in previous years, the company achieved net sales of 21.50 Cr in March 2025, marking a significant increase from 0.24 Cr in March 2024. This growth is mirrored in the total operating income, which also reached 21.50 Cr in March 2025. The operating profit has turned positive, with a reported 0.34 Cr in March 2025, compared to a loss of 0.11 Cr in March 2024. Profit before tax and profit after tax have both shown substantial increases, reaching 0.32 Cr and 0.25 Cr respectively in March 2025, indicating improved profitability. The earnings per share have also risen to 0.71, reflecting the company's enhanced financial health. Overall, Integ. Proteins has transitioned from a period of minimal activity to a phase of significant growth and profitability.